During the
early 1990s, the World Health Organization (WHO) had been
overseeing massive vaccination campaigns against tetanus in a
number of countries, among them Nicaragua, Mexico, and the
Philippines. In October 1994, HLI received a communication
from its Mexican affiliate, the Comite' Pro Vida de Mexico,
regarding that country's anti-tetanus campaign. Suspicious of
the campaign protocols, the Comite' obtained several vials of
the vaccine and had them analyzed by chemists. Some of the
vials were found to contain human chorionic gonadotrophin
(hCG), a naturally occurring hormone essential for maintaining
a pregnancy.
hCG and Anti-hCG Antibodies
In nature the hCG hormone alerts the woman's body that she
is pregnant and causes the release of other hormones to
prepare the uterine lining for the implantation of the
fertilized egg. The rapid rise in hCG levels after conception
makes it an excellent marker for confirmation of pregnancy:
when a woman takes a pregnancy test she is not tested for the
pregnancy itself, but for the elevated presence of hCG.
However, when introduced into the body coupled with a
tetanus toxoid carrier, antibodies will be formed not only
against tetanus but also against hCG. In this case the
body fails to recognize hCG as a friend and will produce
anti-hCG antibodies. The antibodies will attack subsequent
pregnancies by killing the hCG which naturally sustains a
pregnancy; when a woman has sufficient anti-hCG antibodies in
her system, she is rendered incapable of maintaining a
pregnancy.(1)
HLI reported the sketchy facts regarding the Mexican
tetanus vaccines to its World Council members and affiliates
in more than 60 countries.(2) Soon additional reports of
vaccines laced with hCG hormones began to drift in from the
Philippines, where more than 3.4 million women were recently
vaccinated. Similar reports came from Nicaragua, which had
conducted its own vaccination campaign in 1993.
The Known Facts
Here are the known facts concerning the tetanus vaccination
campaigns in Mexico and the Philippines:
* Only women are vaccinated, and only the women between the
ages of 15 and 45. (In Nicaragua the age range was 12-49.) But
aren't men at least as likely as young women to come into
contact with tetanus? And what of the children? Why are they
excluded?
* Human chorionic gonadotrophin (hCG) hormone has been
found in the vaccines. It does not belong there -- in the
parlance of the O.J. Simpson murder trial, the vaccine has
been "contaminated."
* The vaccination protocols call for multiple injections --
three within three months and a total of five altogether. But,
since tetanus vaccinations provide protection for ten years or
more, why are multiple inoculations called for?(3)
* WHO has been actively involved for more than 20 years in
the development of an anti-fertility vaccine utilizing hCG
tied to tetanus toxoid as a carrier -- the exact same coupling
as has been found in the Mexican-Philippine-Nicaragua
vaccines.(4)
The Anti-Fertility Gang
Allied with the WHO in the development of an anti-fertility
vaccine (AFV) using hCG with tetanus and other carriers have
been UNFPA, the UN Development Programme (UNDP), the World
Bank, the Population Council, the Rockefeller Foundation, the
All India Institute of Medical Sciences, and a number of
universities, including Uppsala, Helsinki, and Ohio State.(5)
The U.S. National Institute of Child Health and Human
Development (part of NIH) was the supplier of the hCG hormone
in some of the AFV experiments.(6)
The WHO begain its "Special Programme" in human
reproduction in 1972, and by 1993 had spent more than $356
million on "reproductive health" research.(7) It is this
"Programme" which has pioneered the development of the
abortificant vaccine. Over $90 million of this Programme's
funds were contributed by Sweden; Great Britain donated more
than $52 million, while Norway, Denmark and Germany kicked in
for $41 million , $27 million, and $12 million, respectively.
The U.S., thanks to the cut-off of such funding during the
Reagan-Bush administrations, has contributed "only" $5.7
million, including a new payment in 1993 by the Clinton
administration of $2.5 million. Other major contibutors to the
WHO Programme include UNFPA, $61 million; the World Bank,
$15.5 million; the Rockefeller Foundation, $2.5 million; the
Ford Foundation, over $1 million; and the IDRC (International
Research and Development Centre of Canada), $716.5 thousand.
WHO and Philippine Health Department
Excuses
When the first reports surfaced in the Philippines of
tetanus toxoid vaccine being laced with hCG hormones, the WHO
and the Philippine Department of Health (DOH) immediately
denied that the vaccine contained hCG. Confronted with the
results of laboratory tests which detected its presence in
three of the four vials of tetanus toxoid examined, the WHO
and DOH scoffed at the evidence coming from "right-to-life and
Catholic" sources. Four new vials of the tetanus vaccine were
submitted by DOH to St. Luke's (Lutheran) Medical Center in
Manila -- and all four vials tested positive for hCG!
From outright denial the stories now shifted to the
allegedly "insignificant" quantity of the hCG present; the
volume of hCG present is insufficient to produce anti-hCG
antibodies.
But new tests designed to detect the presence of hCG
antibodies in the blood sera of women vaccinated with the
tetauns toxoid vaccine were undertaken by Philippine pro-life
and Catholic groups. Of thirty women tested subsequent to
receiving tetanus toxoid vaccine, twenty-six tested positive
for high levels of anti-hCG! If there were no hCG in the
vaccine, or if it were present in only "insignificant"
quantities, why were the vaccinated women found to be
harboring anti-hCG antibodies? The WHO and the DOH had no
answers.
New arguments surfaced: hCG's apparent presence in the
vaccine was due to "false positives" resulting from the
particular substances mixed in the vaccine or in the chemicals
testing for hCG. And even if hCG was really there, its
presence derived from the manufacturing process.
But the finding of hCG antibodies in the blood sera of
vaccinated women obviated the need to get bogged down in such
debates. It was no longer necessary to argue about what may or
may not have been the cause of the hCG presence, when
one now had the effect of the hCG. There is no known
way for the vaccinated women to have hCG antibodies in their
blood unless hCG had been artificially introduced into their
bodies!
Why A Tetanus Toxoid "Carrier"?
Because the human body does not attack its own naturally
occurring hormone hCG, the body has to be fooled into treating
hCG as an invading enemy in order to develop a successful
anti-fertility vaccine utilizing hCG antibodies. A paper
delivered at the 4th International Congress of Reproductive
Immunology (Kiel, West Germany, 26-29 July 1989) spelled it
out: "Linkage to a carrier was done to overcome the
immunological tolerance to hCG."(8)
Vaccine Untested by Drug Bureau
After the vaccine controversy had reached a fever pitch, a
new bombshell exploded; none of the three different brands of
tetanus vaccine being used had ever been licensed for sale and
distribution or registered with the Philippine Bureau of Food
and Drugs (BFAD), as required by law. The head of the BFAD
lamely explained that the companies distributing these brands
"did not apply for registration."(9) The companies in question
are Connaught Laboratories Ltd. and Intervex, both from
Canada, and CSL Laboratories from Australia.
It seemed that the BFAD might belatedly require re-testing,
but the idea was quickly rejected when the Secretary of Health
declared that, since the vaccines had been certified by the
WHO -- there they are again! -- there was assurance enough
that the "vaccines come from reputable manufacturers."(10)
Just how "reputable" one of the manufacturers might be is
open to some question. In the mid-`80s Connaught Laboratories
was found to be knowingly distributing vials of
AIDS-contaminated blood products.(11)
Epilogue
At this juncture, evidence is beginning to appear from
Africa.(12) HLI has called for a Congressional investigation
of the situation, inasmuch as nearly every agency involved in
the development of an anti-fertility vaccine is funded, at
least in part, with U.S. monies.
NOTES:
(1)
"Abortifacient vaccines loom as new threat," HLI Reports,
November 1993, pp. 1-2.
(2) World Council Reports, 28 November 1994, pp.
4-5.
(3) A call placed by this writer on 5 May 1995 to the
Montgomery County (Maryland) Health Department, Epidemology
Division -- Infectious Diseases -- Adult Immunizations,
elicited the following information:
Q. For how long a time does the tetanus vaccination
offer protection?
A. 10 years.
Q. Have you ever heard of any adult requiring three
tetanus vaccinations within a 3 or 4 month time period,
and a total of 5 vaccinations in all within a year or
so?
A. Whaaaat! Never. No way!
Reports from the Philippines appear to confirm the 10-year
immunity afforded by tetanus toxoid vaccinations: prior to the
campaigns begun in 1993, the so-called booster shots were
given only every 10 years.
(4) More than a score of articles, many written by WHO
researchers, document WHO's attempts to create an
anti-fertility vaccine utilizing tetanus toxoid as a carrier.
Some leading articles include:
"Clinical profile and Toxicology Studies on Four
Women Immunized with Pr-B-hCG-TT," Contraception,
February, 1976, pp. 253-268.
"Observations on the antigenicity and clinical
effects of a candidate antipregnancy vaccine: B-subunit
of human chorionic gonadotropin linked to tetanus
toxoid," Fertility and Sterility, October 1980,
pp. 328-335.
"Phase 1 Clinical Trials of a World Health
Organisation Birth Control Vaccine," The Lancet,
11 June 1988, pp. 1295-1298. "Vaccines for Fertility
Regulation," Chapter 11, pp. 177-198, Research in
Human Reproduction, Biennial Report (1986-1987), WHO
Special Programme of Research, Development and Research
Training in Human Reproduction (WHO, Geneva 1988).
"Anti-hCG Vaccines are in Clinical Trials,"
Scandinavian Journal of Immunology, Vol. 36, 1992,
pp. 123-126.
(5) These institutional names are garnered from the journal
articles cited in the previous footnote.
(6) Lancet, 11 June 1988, p. 1296.
(7) Challenges in Reproductive Health Research, Biennial
Report 1992-1993, World Health Organization, Geneva, 1994,
p. 186.
(8) G.P. Talwar, et al, "Prospects of an anti-hCG vaccine
inducing antibodies of high affinity...(etc)," Reproductive
Technology 1989, Elsevier Science Publishers, 1990,
Amsterdam, New York, p. 231.
(9) "3 DOH vaccines untested by BFAD," The Philippine
Star, 4 April 1995, pp. 1, 12.
(10) "BFAD junks re-testing of controversial shot,"
Manila Standard, 7 April 1995; "DOH: Toxoid vaccines are
safe," The Philippine Star, 7 April 1995.
(11) "Ottawa got blood tainted by HIV." Ottawa Citizen,
4 April 1995.
(12) A nearly two-year old communique from Tanzania tells a
familiar story: tetanus toxoid vaccinations, five in all,
given only to women aged 15-45. Nigeria, too, may have been
victimized; see The Lancet, 4 June 1988, p. 1273.
Credit: Copyright June/July 1995 by James A. Miller,
special correspondent for Human Life International. This
article was originally published in HLI Reports, Human
Life International, Gaithersburg, Maryland; June/July 1995,
Volume 13, Number 8. Permission to reprint granted to
Thinktwice/New Atlantean Press.